Paulo Rangel

Biography

Mr. Rangel received a B.A. in chemistry/biochemistry from the University of California at San Diego and an M.B.A. from Duke University.Mr. Rangel was the head of Business Development at Arizeke Pharmaceuticals, a respiratory company, from December 2000 to August 2006.  While at Arizeke, Mr. Rangel completed license agreements, renegotiated existing agreements and was responsible for intellectual property, business planning, evaluation of new product opportunities and certain financial projects.  Prior to joining Arizeke, Mr. Rangel was Director of Business Development at Universal Preservation Technologies from September 1998 to December 2000.  Between 1990 and 1998, Mr. Rangel was in the finance department at Hybritech, Inc. and was also involved in the start-up of four biotechnology companies, two of which were successfully acquired by large companies.  Earlier, he was at Amgen Inc., focused on the process scale-up of erythropoietin.Mr. Rangel was a Founder, President & CEO of Lasercure Sciences, a medical device start-up focused on the use of lasers to treat diabetic foot ulcers and pain. Mr. Rangel completed the financing, a diabetic foot ulcer clinical study, two collaborations, and filed two patents (an inventor on both).  Before Lasercure, Mr. Rangel was a Founder and Chief Business Officer of 5i Sciences, a start-up focused on a new approach to treat sleep apnea.  As CBO, Mr. Rangel is responsible for the company’s intellectual property, finance, and general strategy.Paulo S. Rangel concentrates on working with biopharmaceutical and medical device companies on worldwide in- and out-licensing.

Research Interest

Business Management